Login / Signup

Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19.

Marianna KarachaliouOtavio RanzaniAna EspinosaSusana Iraola-GuzmánGemma Castaño-VinyalsMarta VidalAlfons JiménezMarc BañulsEva Alonso NoguésRuth AguilarJudith Garcia-AymerichRafael de CidCarlota DobanoGemma MoncunillManolis Kogevinas
Published in: Journal of medical virology (2024)
Limited research suggests that certain viruses reactivate in severe-acute-respiratory-syndrome-coronavirus 2 infection, contributing to the development of postacute sequelae of COVID-19 (PASC). We examined 1083 infected individuals from a population-based cohort, and assessed differences in plasma immunoglobulin (Ig)G and immunoglobulin A levels against Epstein-Barr virus (EBV), cytomegalovirus, varicella zoster virus (VZV), BK polyomavirus, KI polyomavirus, WU polyomavirus (WUPyV), respiratory syncytial virus, and Adv-36 according to the severity of previous COVID-19 and PASC history. Individuals who had experienced severe COVID-19 had higher antibody responses to latent viruses. Ever PASC, active persistent PASC, and PASC with neuropsychiatric symptoms were associated with higher immnoglobulin G to EBV early antigen-diffuse, VZV, and WUPyV even among individuals without previous severe COVID-19.
Keyphrases
  • coronavirus disease
  • sars cov
  • epstein barr virus
  • respiratory syndrome coronavirus
  • diffuse large b cell lymphoma
  • respiratory syncytial virus
  • squamous cell carcinoma
  • lymph node
  • sleep quality
  • physical activity